GPR132 and breast carcinoma: Because GPR132 is reported to be sensitive to lactate in the breast cancer microenvironment (12), we treated GPR132-deficient NK92 cells and normal NK92 cells with lactate, and the results demonstrated that the GPR132 knockdown can lessen lactate-induced inhibition of NK92 cells.